$AMMJ Announces New York Application Submission

 American Cannabis Company, Inc. (AMMJ) (the “Company”), a full-service cannabis industry consultant and provider of proprietary and preferred products, today announced updates to its advisory and consulting business focused on assisting clients in applying for state licenses to open and operate legal cannabis facilities and dispensaries in states with state regulated programs.

On June 4, 2015 the Company completed and submitted on behalf of its client an application pursuant to the Compassionate Care Program administered by the State of New York Department of Health. The State of New York announced that it would award five licenses to operate cannabis cultivation and processing facilities for the purpose of medicinal cannabis oil production. Additionally, each licensee will have the right to operate four retail medicinal cannabis oil dispensary locations throughout the state. The State of New York intends to award and issue the licenses during the summer of 2015. Should the Company’s client be awarded a license, the Company will commence consulting to focus first on the facility design, deployment, employee training, and on-going operational consulting of a cannabis oil cultivation and processing facility, and second on the dispensary facilities, with the plan of opening retail medicinal dispensaries in early 2016.

The Company has also begun preparing an application for a Florida client to advise and assist with the preparation and submission of a completed application under the Florida Compassionate Care Program. The Florida law is focused on providing a legal framework for the accessibility of prescription medicinal cannabis oil to patients suffering from cancer or medical conditions that chronically produce symptoms of seizures or severe and persistent muscle spasms. The Company’s engagement is underway, and the Company expects to timely file its client’s application prior to the deadline of July 6, 2015. The State of Florida plans on issuing five licenses for establishing facilities to cultivate and process medicinal cannabis oils. Successful applicants will be eligible to open an unlimited number of retail medicinal dispensaries. Subject to Florida granting the Company’s client a license, the Company will consult and advise with regard to the facility design, deployment, employee training, and on-going operations of the cultivation and oil processing facility and medicinal retail outlets.

The Company also announced an initial consulting contract with a Maryland firm exploring the licensing and development of a legal cannabis business in Maryland, pursuant to Maryland’s recently passed law H.B. 490, allowing licensed entities to process medical cannabis, and provide licenses for cultivators, processors and dispensaries. The Company’s efforts here are in the pre- planning stages. However, the Company expects that by establishing relationships with newly established businesses exploring the industry, longer term and more lucrative revenue producing contracts will ensue, including the sales of products and services in the cultivating, refining and dispensing markets.

Company President Corey Hollister commented, “We are very excited for our clients in New York, Florida and Maryland. We are hopeful that all of the hard work devoted to the New York and Florida applications will result in licenses to cultivate, process and dispense medical cannabis and bring the best possible medicine to patients. Because of the limited number of available licenses and the large markets in New York and Florida, we certainly hope to further establish our reputation by helping to secure marquee licenses for our clients and demonstrate our nationwide expertise, capabilities and brand recognition.”

About American Cannabis Company:

American Cannabis Company offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.

For more information, please visit: www.americancannabisconsulting.com.

Forward Looking Statements:

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visitwww.sec.gov.

Contact:

Trent Woloveck
Chief Operating Officer
trent@americancannabisconsulting.com
(303) 974-4770

SOURCE: American Cannabis Company, Inc.